SCHEMBL4491049

SCHEMBL4491049

COc1ccc(-c2ccc3c(NC(=O)NCCCN4CCCC4=O)n[nH]c3c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.64
ALDH1A1 P00352 6/20 0.58
RCE1 Q9Y256 1/20 0.53
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
GAA P10253 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
MAPT P10636 2/20 0.50
HSD17B10 Q99714 2/20 0.50
NPC1 O15118 1/20 0.50
ATM Q13315 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
KMT2A Q03164 1/20 0.49
RAB9A P51151 2/20 0.48
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4481521 0.93 NPC1 (0.56) SMN1; SMN2ALDH1A1RCE1HDAC1HDAC2
SCHEMBL4490770 0.91 KMT2A (0.54) SMN1; SMN2ALDH1A1CYP1A2CYP2C19HSD17B10
SCHEMBL4491703 0.87 ALDH1A1 (0.55) SMN1; SMN2ALDH1A1RCE1HDAC1HDAC2
SCHEMBL4490101 0.87 KMT2A (0.52) SMN1; SMN2ALDH1A1CYP1A2CYP2C19NPC1
SCHEMBL4490556 0.85 GSK3B (0.54) SMN1; SMN2ALDH1A1HDAC1HDAC2HDAC8
SCHEMBL12886394 0.83 HDAC6 (0.50) SMN1; SMN2CYP1A2NPC1HDAC6KMT2A
SCHEMBL4486921 0.83 HDAC6 (0.55) HDAC1HDAC2HDAC8HDAC6KDM4E
SCHEMBL4476091 0.82 HDAC1 (0.52) HDAC1HDAC2HDAC8HDAC6
SCHEMBL4502964 0.82 HDAC1 (0.63) HDAC1HDAC2HDAC8HDAC6
SCHEMBL4489897 0.82 HDAC1 (0.63) HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed